About Kieron Jones
Form D filings for K2 Biolabs from 2021 to 2023 list Kieron Jones as executive officer and director.
Kieron Jones first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Kieron Jones in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kieron Jones works with at each company, as listed on that company's latest Form D.
K2 Biolabs, Inc. · Form D, Aug 2, 2023
AD
Andrew DeSomma
Member of the Board of Directors
GF
Gerard Fleury
Member of the Board of Directors
CS
Clifford Stocks
Member of the Board of Directors
AS
Andrew Strong
Member of the Board of Directors
DC
Daniel Clark
Chief Financial Officer
KS
Kevin Slawin
Member of the Board of Directors